<Home — Psychoactive Plant Database



  Psychoactive Plant Database - Neuroactive Phytochemical Collection





Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.

 

 

1. Nucleosides Nucleotides Nucleic Acids. 2024 Nov 7:1-14. doi: 10.1080/15257770.2024.2426160. Online ahead of print. In memory of an exquisite medicinal chemist, Prof. Morris Robins. De Clercq E(1). Author information: (1)Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, B-3000Leuven, Belgium. Among the most prominent realizations of Morris J. Robins in the antiviral nucleoside chemistry are (i) the synthesis of 8-substituted (methyl-, amino-, bromo-, iodo) derivatives of acyclovir, (ii) xylotubercidin as an inhibitor of herpes simplex virus (HSV) infections, (iii) the anti-HIV activity of the 2',3'-dideoxyriboside of 2,6-diaminopurine (ddDAPR) and the 3'-azido- and 3'-fluoro derivatives thereof (AzddDAPR and FddDAPR, respectively), (iv) the potentiating effect of ribavirin on the anti-HIV activity of 2',3'-dideoxyinosine (ddI) and ddDAPR, (v) S-adenosylhomocysteine hydrolase (SAH) inhibitors principally active against vaccinia virus (VV) and vesicular stomatitis virus (VSV), and (vi) furo[2,3-d]pyrimidinone derivatives active against varicella-zoster virus (VZV). DOI: 10.1080/15257770.2024.2426160 PMID: 39508253 2. Chem Asian J. 2024 Nov 7:e202400916. doi: 10.1002/asia.202400916. Online ahead of print. Chalcogen Bond-Driven Alkylations: Selenoxide-Pillar[5]arene As A Recyclable Catalyst For Displacement Reactions In Water. Cordeiro P(1), Menezes V(1), Ángel AYB(2), de Andrade KN(1), Fiorot RG(1), Alberto EE(2), Nascimento V(3). Author information: (1)Federal Fluminense University, Organic Chemistry, BRAZIL. (2)Federal University of Minas Gerais, Chemistry, BRAZIL. (3)Universidade Federal Fluminense, Química Orgânica, OUTEIRO DE SÃO JOÃO BATISTA, S/N - CAMPUS DO VALONGUINHO, 24020141, NITERÓI, BRAZIL. A novel strategy to catalyze alkylation reactions through chalcogen bond interaction using a supramolecular structure is presented herein. Utilizing just 1.0 mol% of selenoxide-pillar[5]arene (P[5]SeO) as the catalyst we achieved efficient catalysis in the cyanation of benzyl bromide in water. Our approach demonstrated high efficiency and effectiveness, with the results supported by designed control experiments and theoretical models, highlighting the catalytic effect of the pillar[5]arene through noncovalent interactions. Quantum-chemical calculations (ωB97X-D/def2-TZVP@SMD) pointed out that the catalyzed cyanation reaction followed an SN2-like mechanism, with energy barriers (ΔH‡) ranging from 16.7 to 18.2 kcal mol-1, exhibiting dissociative character depending on the para-substituent. 1H NMR analysis revealed that P[5]SeO acted as a catalyst through inclusion complex formation, facilitating the transfer of the electrophilic substrate to the aqueous solution for nucleophilic displacement. Our reaction protocol proved applicable to various substrates, including aromatic and alpha-carbonyl derivatives. The use of sodium azide as the nucleophile was also feasible. Importantly, our method allowed scalability, and the catalyst P[5]SeO could be recovered and reused effectively for multiple reaction cycles, showcasing sustainability. © 2024 Wiley‐VCH GmbH. DOI: 10.1002/asia.202400916 PMID: 39508242 3. BMC Neurosci. 2024 Nov 6;25(1):68. doi: 10.1186/s12868-024-00893-w. The social and neural bases of creative movement: workshop overview. Shamma S(1)(2), Contreras-Vidal J(3), Fritz J(4), Lim SS(5), Tuller B(5), Edwards E(6), Iyengar S(7). Author information: (1)Institute for Systems Research, University of Maryland, College Park, MD, USA. sas@umd.edu. (2)Le Département d'Etudes Cognitives, École Normale Supérieure, Paris, France. sas@umd.edu. (3)IUCRC BRAIN, University of Houston, Houston, TX, USA. (4)Center for Neural Science, New York University, New York City, NY, USA. (5)National Science Foundation, Alexandria, VA, USA. (6)National Institutes of Health, Bethesda, MD, USA. (7)National Endowment for the Arts, Washington, DC, USA. This editorial provides a background and overview of the interdisciplinary workshop on "The Social and Neural Bases of Creative Movement," bringing together dancers, choreographers, musicians, artists, kinesiologists and neuroscientists to share perspectives and develop a common language to define and explore the relationship between dance and the brain. © 2024. The Author(s). DOI: 10.1186/s12868-024-00893-w PMID: 39508234 4. HIV Med. 2024 Nov 7. doi: 10.1111/hiv.13730. Online ahead of print. Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV. Laguno M(1)(2)(3), de Lazzari E(1)(2)(3), Berrocal L(1)(2), Inciarte A(1)(2)(3), Martínez-Rebollar M(1), de la Mora L(1), Torres B(1)(2)(3), Gonzalez-Cordón A(1), Chivite I(1), Foncillas A(1), Calvo J(1), Sempere A(1), Ambrosioni J(1)(2)(3), Blanco JL(1)(2)(3), Miro JM(1)(2)(3), Mallolas J(1)(2)(3), Martínez E(1)(2)(3). Author information: (1)HIV Unit, Infectious Diseases Service. Hospital Clínic of Barcelona, Barcelona, Spain. (2)Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer. (IDIBAPS), Barcelona, Spain. (3)Centro de Investigación Biomédica en Red, CIBERINFEC, Madrid, Spain. BACKGROUND: Liver steatosis (LS) and liver fibrosis (LF) can increase the risk of cardiovascular disease in people with HIV, but their prevalence and associated factors are poorly understood. This study aimed to assess the prevalence of and factors associated with LS and LF in a large cohort of people with HIV. METHODS: We conducted a cross-sectional study of consecutive people with HIV attending the Clinic of Barcelona from September 2022 to September 2023, excluding those with chronic B or/and C hepatitis virus coinfection. LS was assessed using the Hepatic Steatosis Index (HSI) and Fatty Liver Index (FLI), and LF was assessed using the Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), Fibrosis-4 score (FIB-4), and the European AIDS Clinical Society (EACS) algorithm in both the whole cohort (cohort 1) and in a specific cohort more susceptible to liver disease (cohort 2). We identified independent variables associated with LS and LF using logistic regression. RESULTS: Cohort 1 included 4664 people with HIV; 76% and 37% of them had available HSI and FLI data, LS was present in 28% and 19%, respectively. LF risk was present in 1%, 2%, and 1% of people with HIV according to NFS, FIB-4, and EACS algorithm scores, respectively. Cohort 2 included 1345 people with HIV; 60% and 30% of them had available HSI and FLI data, LS affected 55% and 43% and LF 2%, 5%, or 3%, respectively. Factors associated with LS included current CD4 cell count, diabetes, and hypertension, whereas LF was associated with previous exposure to dideoxynucleoside drugs and current CD4 to LF. Current integrase strand transfer inhibitor (INSTI) therapy appeared protective for LF in cohort 1. CONCLUSIONS: In this study, one in four people with HIV had LS, and the prevalence rose to one in two in those with cardiovascular risk factors. The prevalence of LF was low, but it should be considered in older people with HIV with low CD4 counts or high aspartate transaminase levels. A possible protective effect from INSTIs deserves further investigation. © 2024 The Author(s). HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association. DOI: 10.1111/hiv.13730 PMID: 39508213 5. Adv Clin Exp Med. 2024 Nov 7. doi: 10.17219/acem/191774. Online ahead of print. Effect of reduced saturation and elevated D-dimer and interleukin 6 levels on vessel density and foveal avascular zone in patients with COVID-19 bilateral pneumonia. Kal M(1)(2), Brzdęk M(1)(3), Cieśla E(4), Rzymski P(5), Karska-Basta I(6), Pinna A(7), Mackiewicz J(8), Winiarczyk M(8), Odrobina D(2)(9), Zarębska-Michaluk D(1)(3). Author information: (1)Collegium Medicum of Jan Kochanowski University in Kielce, Poland. (2)Ophthalmic Clinic of the Voivodeship Hospital in Kielce, Poland. (3)Department of Infectious Diseases and Allergology, Jan Kochanowski University in Kielce, Poland. (4)Institute of Health Sciences, Jan Kochanowski University in Kielce, Poland. (5)Department of Environmental Medicine, Poznan University of Medical Sciences, Poland. (6)Department of Ophthalmology, Clinic of Ophthalmology and Ocular Oncology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland. (7)Department of Medicine, Surgery, and Pharmacy, Ophthalmology Unit, University of Sassari, Italy. (8)Department of Vitreoretinal Surgery, Medical University of Lublin, Poland. (9)Insitute of Medical Science, Jan Kochanowski University in Kielce, Poland. BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can affect multiple organs, including the eyes. OBJECTIVES: This study aimed to identify associations between vascular density (VD) and the foveal avascular zone (FAZ), assessed using optical coherence tomography angiography (OCTA), and baseline levels of D-dimers and interleukin 6 (IL-6) in patients with bilateral COVID-19 pneumonia, depending on oxygen saturation (SpO2) on admission. MATERIAL AND METHODS: The study included patients with COVID-19 bilateral pneumonia due to SARS-CoV-2 infection who were hospitalized between March and May 2021. Ophthalmological examination was performed 2 months after hospitalization. Optical coherence tomography angiography was used for the automatic assessment of the central retinal VD and the manual assessment of FAZ. RESULTS: A significant monotonic negative relationship was observed between SpO2 . 90% and VD in some areas of the superficial capillary plexus (SCP) (p = 0.048) and choriocapillaris (p = 0.021), and the mean VD in the deep capillary plexus (DCP) (p = 0.048). No significant monotonic negative relationship was noted between SpO2 . 90% and the FAZ in the SCP (p = 0.075). However, there was a significant monotonic positive relationship between VD in the nasal choriocapillaris and D-dimer levels in patients with SpO2 . 90% (p = 0.003, respectively). Finally, a monotonic negative relationship was identified between foveal VD in the DCP and IL-6 levels in patients with SpO2 . 90% (p = 0.027). CONCLUSIONS: An OCTA study conducted 2 months after hospitalization for COVID-19 bilateral pneumonia showed reduced VD in those with SpO2 . 90% and elevated levels of D-dimers and IL-6 during hospitalization. Optical coherence tomography angiography testing can provide monitoring of ocular status in patients following SARS-CoV-2 infection, especially those who report visual disturbances. DOI: 10.17219/acem/191774 PMID: 39508210